New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections
ZA200604180B
Oxazolidinone-quinolone hybrid antibiotics
MXPA06002366A
Intermediate products for producing oxazolidinone-quinolone hybrids.
DE102004041163A1
New compounds with antibacterial activity
DE102004034913A1
Novel compounds that inhibit factor Xa activity
BRPI0409955A
use of hybrid oxazolidinone - quinoline antibiotics to treat anthrax and other infections
EP1557416A1
Oxazolidinone-quinolone hybrid antibiotics
AU2003296242A1
Thia-epothilone derivatives for the treatment of cancer
US2004132764A1
Antibiotics for the treatment of infections in acidic environments
CA2500320A1
Novel compounds with antibacterial activity
NZ539217A
Bicyclic quinoline derivative compounds having antibacterial activity
DE10344882A1
New macrocycles for the treatment of cancer
DE10342292A1
New macrolide oxazolidinone derivatives useful for treating bacterial infections
AU2003266233A1
Novel tubulysin analogues
DE10327472A1
New thia-epothilone derivatives useful in the preparation of medicaments for the treatment of cancer
DE10309005A1
New conjugates comprising a dipeptidyl peptidase inhibitor linked to a neural endopeptidase inhibitor, e.g. useful for treating diabetes, obesity, growth hormone deficiency, immunosuppression, HIV infection
NZ534238A
Compounds that inhibit factor Xa activity
DE10256405A1
New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens
DE10255660A1
New macrocycles useful for the treatment of cancer
